Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 22;20(Suppl 3):78.
doi: 10.1186/s13223-024-00936-1.

Drug allergy

Affiliations
Review

Drug allergy

Samira Jeimy et al. Allergy Asthma Clin Immunol. .

Abstract

Drug allergy encompasses a spectrum of immunologically-mediated hypersensitivity reactions (HSRs) with varying mechanisms and clinical presentations. This type of adverse drug reaction (ADR) not only affects patient quality of life, but may also lead to delayed treatment, unnecessary investigations, and increased morbidity and mortality. Given the spectrum of symptoms associated with the condition, diagnosis can be challenging. Therefore, referral to an allergist experienced in the diagnosis and management of drug allergy is recommended if a drug-induced allergic reaction is suspected. Diagnosis relies on a careful history and physical examination and, in some instances, skin testing or in vitro testing and drug challenges. The most effective strategy for the management of allergist-confirmed drug allergy is avoidance or discontinuation of the offending drug. When available, alternative medications with unrelated chemical structures should be substituted. Cross-reactivity among drugs should also be taken into consideration when choosing alternative agents. Additional therapy for drug HSRs may include topical corticosteroids, oral antihistamines and, in severe cases, systemic corticosteroids and other immunomodulators. In the event of anaphylaxis, the treatment of choice is intramuscular epinephrine. If a patient with a history of anaphylaxis requires a specific drug and there is no acceptable alternative, desensitization to that drug may be considered. This article provides a background on drug allergy and strategies for the diagnosis and management of some of the most common drug-induced allergic reactions.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: Dr. Samira Jeimy has received consulting fees and honoraria from Sanofi, GSK, ALK, AstraZeneca, Medexus, Stallergenes Greer and Novartis. Dr. Moshe Ben-Shoshan has received consulting fees from Novartis and Sanofi. Dr. Anne K. Ellis has participated in advisory boards for AstraZeneca. ALK Abello, Bausch, Circassia Ltd, GlaxoSmithKline, Merck and Novartis, and has been a speaker for ALK Abellos, AstraZeneca, Mylan, Merck, Novartis, Pfizer, Sanofi, Regeneron and Takeda. Her institution has received research grants from Bayer LLC, Circassia Ltd, Green Cross Pharmaceuticals, GlaxoSmithKline, Sun Pharma, Merck, Novartis, Pfizer, Sanofi and Regeneron. Dr. Ellis is also a former consultant to ALK-Abello Canada and Bayer Consumer Health Division. Dr. Ghislaine A.C. Isabwe, Dr. Ana Maria Copaescu and Dr. Tiffany Wong have no competing interests to disclose.

Figures

Fig. 1
Fig. 1
Drug allergy classification based on phenotypes and endotypes [9, 14]. AECD: aspirin-exacerbated cutaneous disease; AERD: aspirin-exacerbated respiratory disease; AGEP: acute generalized exanthematous pustulosis; alpha-gal: galactose-alpha-1,3-galactose; COX1: cyclooxygenase-1; DRESS: drug reaction with eosinophilia and systemic symptoms; HLA: human leukocyte antigen; IgE: immunoglobulin E; mAb: monoclonal antibody; MRGPRX2: Mas-related G protein-coupled receptor; NSAID, non-steroidal anti-inflammatory drug; SJS: Stevens-Johnson syndrome; TEN: toxic epidermal necrolysis. Figure adapted from: de Las Vecillas Sánchez et al. [14] and Muraro et al. [9]

References

    1. Khan DA, Solensky R. Drug allergy. J Allergy Clin Immunol. 2010;125:S126–37. - PubMed
    1. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255–9. - PubMed
    1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–5. - PubMed
    1. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates DW. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556–64. - PubMed
    1. Vervloet D, Durham S. Adverse reactions to drugs. BMJ. 1998;316(7143):1511–4. - PMC - PubMed

LinkOut - more resources